Cynapept
Cynapept

Pure · Proven · Precise

Who We Are

UAE-Based Pharmaceutical Innovator, Redefining Global Standards.

Cynapept is a UAE-based pharmaceutical leader that unites Swiss precision engineering with cutting-edge American technology to deliver next-generation metabolic health solutions.

UAE

Headquarters & Strategic Hub

3+

Premium Products Available

99.9%

Purity Guarantee Per Batch

GMP

Certified Manufacturing

Why Cynapept

Precision Built on Global Standards.

UAE Strategic Hub

Headquartered at the crossroads of global trade and logistics.

Swiss Expertise

Precision engineering rooted in Swiss pharmaceutical heritage.

GMP Quality Standards

Every batch manufactured under strict international compliance.

Scientific Innovation

Advancing metabolic medicine through rigorous, ongoing research.

Our Portfolio

Discover What's Possible.

Four formulations, manufactured and verified to the same rigorous standard — across pens, vials, and oral tablets.

Tirzepatide injectable pen packaging
Dual Receptor Agonist · Injectable

Tirzepatide

Injectable Pen

Dual-targeted GLP-1 and GIP receptor agonist delivering clinically validated glycemic control and significant weight reduction.

  • Slows gastric emptying for prolonged satiety and appetite control
  • Robust glycemic control and metabolic regulation in T2DM
  • Highly documented safety profile across global clinical studies
Strengths 10 · 20 · 30 · 40 · 50 · 60 mg
Retatrutide injectable pen packaging
Triple Receptor Agonist · Injectable

Retatrutide

Injectable Pen

The world's most powerful triple-agonist peptide targeting GLP-1, GIP, and Glucagon receptors simultaneously for superior metabolic regulation.

  • Proven up to 24% body weight reduction in clinical trials
  • Strongest efficacy in class with direct fat-burning pathways
  • GMP-certified, cold-chain maintained, batch-tested ≥99.9% purity
Strengths 10 · 20 · 40 mg
Retatrutide lyophilized vial packaging
Triple Receptor Agonist · Lyophilized

Retatrutide

Lyophilized Vial

High-purity lyophilized Retatrutide formulation for extended stability — ideal for research facilities and clinical applications.

  • Verified ≥99.9% purity via HPLC certificate of analysis
  • Freeze-dried to maintain peak stability and long shelf life
  • Zero additives, stabilizers, or fillers — pharmaceutical grade
Strengths 10 · 20 · 40 · 60 mg
Orforglipron oral tablets packaging
Oral GLP-1 Receptor Agonist · Non-peptide

Orforglipron

Oral Tablets

Next-generation oral non-peptide GLP-1 receptor agonist — effective metabolic therapy without injections.

  • No needles — simple once-daily tablet administration
  • Directly stimulates GLP-1 receptors for appetite regulation
  • Room-temperature stable — easy to store and travel with
Strengths 0.8 · 2.5 · 5.5 · 9 · 14.5 mg
Compare Formulations

Product Comparison

Evaluate mechanisms, administration methods, and patient profile targets across our formulations.

Retatrutide

Mechanism
Triple Agonist (GLP-1 / GIP / GCG)
Administration
Weekly Injection
Primary Target
Maximum Weight Reduction
Patient Profile
Treatment Resistant Cases

Tirzepatide

Mechanism
Dual Agonist (GLP-1 / GIP)
Administration
Weekly Injection
Primary Target
Obesity & T2D Control
Patient Profile
Mainline Clinical Patients

Orforglipron

Mechanism
Oral Agonist (GLP-1)
Administration
Daily Tablet
Primary Target
Convenient Weight Mgmt
Patient Profile
Preference for Oral Therapy
Manufacturing Excellence

Built on Precision, Delivered with Integrity.

Every formulation we ship is manufactured and verified to the same rigorous standard, from raw material to final delivery.

GMP-Certified Manufacturing

Every Cynapept product is manufactured in GMP-certified facilities, adhering to the strictest international pharmaceutical standards across all production stages.

Cold Chain Integrity

Our dedicated cold-chain logistics ensure temperature-sensitive peptides maintain full potency and stability from production through final delivery.

Multi-Stage Quality Assurance

Each batch undergoes comprehensive HPLC analysis, sterility testing, and independent third-party verification to guarantee ≥99.9% purity.

Scalable Production Capacity

Our infrastructure is engineered for global-scale output, ensuring consistent availability and rapid response to growing international demand.

Get Product Updates

Leave your email and let us know what you're interested in — we'll keep you posted on new formulations and availability.